Protective effect of interleukin-23A (IL23A) haplotype variants on type 1A diabetes mellitus in a Brazilian population

Cytokine

Volumn 62, Issue 2, 2013, Pages 327-333

  Costa, V S ^a   Santos, A S ^a   Fukui, R T ^a   Mattana, T C C ^a   Matioli, S R ^a   Silva, M E R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Autoimmunity; IL23A; IL23R; T Helper 17 cells; Type1A diabetes

Indexed keywords

ADENINE; C PEPTIDE; GUANINE; INTERLEUKIN 23 ANTIBODY; INTERLEUKIN 23 RECEPTOR; INTERLEUKIN 23P19; AUTOANTIBODY; IL23A PROTEIN, HUMAN; IL23R PROTEIN, HUMAN; INTERLEUKIN RECEPTOR;

ADULT; AGE; ANTIBODY BLOOD LEVEL; ARTICLE; AUTOIMMUNITY; BRAZILIAN; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE DURATION; ETHNIC GROUP; FEMALE; GENE FREQUENCY; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERLEUKIN 23A GENE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SEQUENCE ANALYSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; ALLELE; BLOOD; BRAZIL; DNA SEQUENCE; GENETIC PREDISPOSITION; GENETICS; GENOTYPE; IMMUNOLOGY; METABOLISM; NUCLEOTIDE SEQUENCE; YOUNG ADULT;

ADULT; ALLELES; AUTOANTIBODIES; BASE SEQUENCE; BRAZIL; DIABETES MELLITUS, TYPE 1; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENOTYPE; HUMANS; INTERLEUKIN-23 SUBUNIT P19; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN; SEQUENCE ANALYSIS, DNA; YOUNG ADULT;

EID: 84876812841     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2013.03.015     Document Type: Article

References (38)

1. Mein C.A., Esposito L., Dunn M.G., Johnson G.C., Timms A.E., Goy J.V., et al. A search for type 1 diabetes susceptibility genes in families from the United Kingdom. Nat. Genet. 1998, 19:297-300.
2. Concannon P., Rich S.S., Nepom G.T. Genetics of type 1A diabetes. New Engl J Med 2009, 360:1646-1654.
3. Davies J.L., Kawaguchi Y., Bennett S.T., Copeman J.B., Cordell H.J., Pritchard L.E., et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature 1994, 371:130-136.
4. Martin S., Wolf-Eichbaum D., Duinkerken G., Scherbaum W.A., Kolb H., Noordzij J.G., et al. Development of type 1 diabetes despite severe hereditary B-lymphocyte deficiency. New Engl J Med 2001, 345:1036-1040.
5. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. Distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
6. Honkanen J., Nieminen J.K., Gao R., Luopajarvi K., Salo H.M., Ilonen J., et al. IL-17 immunity in human type 1 diabetes. J Immunol 2010, 185:1959-1967.
7. Arif S., Moore F., Marks K., Bouckenooghe T., Dayan C.M., Planas R., et al. Peripheral and islet interleukin-17 pathway activation characterizes human autoimmune diabetes and promotes cytokine-mediated β-cell death. Diabetes 2011, 60:2112-2119.
8. Langrish C.L., Chen Y., Blumenschein W.M., Mattson J., Basham B., Sedgwick J.D., et al. IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J Exp Med 2005, 205:233-240.
9. Stark M.A., Huo Y., Burcin T.L., Morris M.A., Olson T.S., Ley K. Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity 2005, 22:285-294.
10. Lankford C.S., Frucht D.M. A unique role for IL-23 in promoting cellular immunity. J Leukoc Biol 2003, 73:49-56.
11. Cargill M., Schrodi S.J.V., Chang M., Garcia V.E., Brandon R., Callis K.P., et al. A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 2007, 80:273-290.
12. Liu Y., Helms C., Liao W., Zaba L.C., Duan S., Gardner J., et al. A genome wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 2008, 4:e1000041.
13. Núñez C., Dema B., Cénit M.C., Polanco I., Maluenda C., Arroyo R., et al. IL23R: a susceptibility locus for celiac disease and multiple sclerosis?. Genes Immun 2008, 9:289-293.
14. Sáfrány E., Pazár B., Csöngei V., Járomi L., Polgár N., Sipeky C., et al. Variants of the IL23R gene are associated with ankylosing spondylitis but not with sjogren syndrome in hungarian population samples. Scand J Immun 2009, 70:64-68.
15. Chen Y.C., Chen S.D., Miao L., Liu Z.G., Li W., Zhao Z.X., et al. IL-23 and IL-17 in Chinese patients with multiple sclerosis. J Neuroimmunol 2012, 243:56-60.
16. Shen H., Xia L., Lu J., Xiao W. Interleukin-17 and interleukin-23 in patients with polymyositis and dermatomyositis. Scand J Rheumatol 2011, 40:217-220.
17. American Diabetes Association (ADA).http://www.diabetes.org.
18. Yi T., Lee D.D.S., Jeon M.S., Kwon S.W., Song S.U. Gene expression profile reveals that STAT2 is involved in the immunosuppressive function of human bone marrow-derived mesenchymal stem cells. Gene 2012, 497:131-139.
19. Platanias L.C. Mechanisms of type-I- and type-II-interferon-mediated signalling. Nat Rev Immunol 2005, 5:375-386.
20. Molnár A., Georgopoulos K. The Ikaros gene encodes a family of functionally diverse zinc finger DNA-binding proteins. Mol Cell Biol 1994, 14:8292-8303.
21. Nair R.P., Duffin K.C., Helms C., Ding J., Stuart P.E., Goldgar D., et al. Collaborative Association Study of Psoriasis. Genome-wide scan reveals association of psoriasis with IL-23 and NF-kappaB pathways. Nat Genet 2009, 41:199-204.
22. Wahle E., Winkler G.S. RNA decay machines: deadenylation by the Ccr4-Not and Pan2-Pan3 complexes. Biochim Biophys Acta 2013, 19:7-12.
23. Mohammadi M., Hayatbakhsh M.M., Zahedi M.J., Jalalpour M.R., Pakgohar A. Serum Interleukin-23 levels in patients with ulcerative colitis. Iran J Immunol 2011, 8:183-188.
24. Ferraro A., Socci C., Stabilini A., Valle A., Monti P., Piemonti L., et al. Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with Type 1 diabetes. Diabetes 2011, 60:2903-2913.
25. Abbasi F., Amiri P., Sayahpour F.A., Pirmoradi S., Abolhalaj M., Larijani B., et al. TGF-β and IL-23 gene expression in unstimulated PBMCs of patients with diabetes. Endocrine 2012, 41:430-434.
26. Uhlig H.H., McKenzie B.S., Hue S., Thompson C., Joyce-Shaikh B., Stepankova R., et al. Differential activity of IL-12 and IL-23 in mucosal and systemic innate immune pathology. Immunity 2006, 25:309-318.
27. Hazlett J., Stamp L.K., Merrima T., Highton J., Hessian P.A. IL-23R rs11209026 polymorphism modulates IL-17A expression in patients with rheumatoid arthritis. Genes Immun 2012, 13:282-287.
28. Ciric B., El-behi M., Cabrera R., Zhang G.X., Rostami A. IL-23 drives pathogenic IL-17-producing CD8+ T cells. J Immunol 2009, 182:5296-5305.
29. Enstrom A., Onore C., Hertz-Picciotto I., Hansen R., Croen L., De Water J.V., et al. Detection of IL-17 and IL-23 in plasma samples of children with autism. Am J Biochem Biotech 2008, 4:114-120.
30. Duerr R.H., Taylor K.D., Brant S.R., Rioux J.D., Silverberg M.S., Daly M.J., et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 2006, 314:1461-1463.
31. Pidasheva S., Trifari S., Phillips A., Hackney J.A., Ma Y., Smith A., et al. Functional studies on the IBD susceptibility gene IL23R implicate reduced receptor function in the protective genetic variant R381Q. PLoS One 2011, 6:e25038.
32. Di Meglio P., Di Cesare A., Laggner U., Chu C.C., Napolitano L., Villanova F., et al. The IL23R R381Q gene variant protects against immune-mediated diseases by impairing IL-23-induced Th17 effector response in humans. PLoS One 2011, 6:e17160.
33. Sarin R., Wu X., Abraham C. Inflammatory disease protective R381Q IL23 receptor polymorphism results in decreased primary CD4+ and CD8+ human T-cell functional responses. Proc Natl Acad Sci USA 2011, 108:9560-9565.
34. Ban Y., Tozaki T., Taniyama M., Nakano Y., Yoneyama K., Ban Y., et al. Association studies of the IL-23R gene in autoimmune thyroid disease in the Japanese population. Autoimmunity 2009, 42:126-130.
35. Li Y., Liang W.B., Li C., Gao L.B., Zhou B., Wang Y.Y., et al. The Association between Interleukin-23 receptor gene polymorphisms and systemic lupus erythematosus. DNA Cell Biol 2010, 29:79-82.
36. Abraham C., Cho J. Interleukin-23/Th17 pathways and inflammatory bowel disease. Inflamm Bowel Dis 2009, 15:1090-1100.
37. Bosi E., Molteni L., Radaelli M.G., Folini L., Fermo I., Bazzigaluppi E., et al. Increased intestinal permeability precedes clinical onset of type 1 diabetes. Diabetologia 2006, 49:2824-2827.
38. Alam C., Valkonen S., Palagani V., Jalava J., Eerola E., Hänninen A. Inflammatory tendencies and overproduction of IL-17 in the colon of young NOD mice are counteracted with diet change. Diabetes 2010, 59:2237-2246.